Related Experiment Videos
Spinal and cranial hypertrophic neuropathy in multiple sclerosis
Dianna Quan1, Victoria Pelak, Jody Tanabe
1Department of Neurology, University of Colorado Health Sciences Center, Box F727, 4200 East Ninth Avenue, Denver, Colorado 80262, USA. dianna.quan@uchsc.edu
Muscle & Nerve
|March 29, 2005
Summary
Two patients with multiple sclerosis and chronic inflammatory demyelinating polyneuropathy showed severe nerve enlargement. Standard treatments were ineffective, suggesting unique disease mechanisms and the need for further therapeutic exploration.
Area of Science:
- Neurology
- Neuroimmunology
- Peripheral Nervous System Disorders
Background:
- Multiple sclerosis (MS) typically involves central nervous system demyelination.
- Chronic inflammatory demyelinating polyneuropathy (CIDP) affects the peripheral nervous system.
- Coexistent central and peripheral demyelination is uncommon and presents diagnostic challenges.
Observation:
- Two patients with MS developed symptomatic CIDP with significant spinal and cranial nerve hypertrophy.
- Neuroimaging revealed massive nerve enlargement.
- Sural nerve biopsy showed moderate demyelination and axonal loss, with onion-bulb formation.
Findings:
- The nerve biopsy indicated a dichotomy between severe proximal and milder distal nerve involvement.
- Patients experienced symptoms primarily from either central or peripheral nervous system dysfunction, not both.
- Conventional treatments including steroids, intravenous immunoglobulin, and azathioprine yielded minimal response.
Implications:
- The distinct clinical presentation suggests potentially different underlying disease mechanisms in patients with coexistent central and peripheral demyelination.
- These findings highlight the need for further research into optimal therapeutic strategies for this complex neurological condition.
- Further investigation is warranted to understand the pathophysiology and guide treatment for combined central and peripheral demyelination in MS.